Author

Matilde Sanchez

Institution: Arena Pharmaceuticals (United States)

Observed institutions: University of North Carolina at Chapel Hill, Merck & Co., Inc., Rahway, NJ, USA (United States), Pennsylvania State University, Georgetown University, Sanford Burnham Prebys Medical Discovery Institute, Arena Pharmaceuticals (United States), Translational Research Institute for Metabolism and Diabetes, AdventHealth, MedStar Health Research Institute

OpenAlex ID: A5020253646

Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management

2010 · Steven R. Smith, Neil J. Weissman, et al. · New England Journal of Medicine · 919

A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial

2011 · Meredith C. Fidler, Matilde Sanchez, et al. · The Journal of Clinical Endocrinology & Metabolism · 565

Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study

2012 · Patrick M. O'Neil, Steven R. Smith, et al. · Obesity · 525

Lorcaserin, A 5-HT2CReceptor Agonist, Reduces Body Weight by Decreasing Energy Intake without Influencing Energy Expenditure

2010 · Corby K. Martin, Leanne M. Redman, et al. · The Journal of Clinical Endocrinology & Metabolism · 135

Efficacy and Tolerability Profile of Etoricoxib in Patients with Osteoarthritis: A Randomized, Double-blind, Placebo and Active-comparator Controlled 12-Week Efficacy Trial

2002 · Albert T. Leung, Kerstin Malmstrom, et al. · Current Medical Research and Opinion · 115

Echocardiographic Assessment of Cardiac Valvular Regurgitation With Lorcaserin From Analysis of 3 Phase 3 Clinical Trials

2013 · Neil J. Weissman, Matilde Sanchez, et al. · Circulation Cardiovascular Imaging · 65

A systemic type i 5 α-reductase inhibitor is ineffective in the treatment of acne vulgaris

2004 · James Leyden, Wilma Bergfeld, et al. · Journal of the American Academy of Dermatology · 48

APD125, a Selective Serotonin 5-HT2A Receptor Inverse Agonist, Significantly Improves Sleep Maintenance in Primary Insomnia

2008 · Russell Rosenberg, David J. Seiden, et al. · SLEEP · 44

Views on Emerging Issues Pertaining to Data Monitoring Committees for Adaptive Trials

2013 · Zoran Antonijevic, Paul Gallo, et al. · Therapeutic Innovation & Regulatory Science · 19

Pharmacokinetics and Tolerability of Lorcaserin in Special Populations: Elderly Patients and Patients with Renal or Hepatic Impairment

2017 · Ronald J. Christopher, Michael E. Morgan, et al. · Clinical Therapeutics · 7

2010 · Patrick Peterson, Kevin Carroll, et al. · Statistics in Biopharmaceutical Research · 1

Works count: 11

Citation count: 2,443

H-index: 9

I10-index: 9